Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina. Show more
Location: 4020 Stirrup Creek Drive, Durham, NC, 27703, United States | Website: https://pelthos.com | Industry: Biotechnology | Sector: Healthcare
Market Cap
12.32M
52 Wk Range
$4.50 - $54.29
Previous Close
$19.00
Open
$18.36
Volume
13,025
Day Range
$17.95 - $19.42
Enterprise Value
14.9M
Cash
131.3K
Avg Qtr Burn
-1.108M
Insider Ownership
65.68%
Institutional Own.
11.84%
Qtr Updated
03/31/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|